OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
8.64
-0.10 (-1.14%)
At close: Mar 28, 2025, 4:00 PM
8.66
+0.02 (0.21%)
After-hours: Mar 28, 2025, 7:56 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $159.76 million as of March 28, 2025. Its market cap has decreased by -34.95% in one year.
Market Cap
159.76M
Enterprise Value
179.57M
1-Year Change
-34.95%
Ranking
Category
Stock Price
$8.64
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $159.76M, an increase of 367.13%. That is a compound annual growth rate of 25.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 159.80M | 78.55% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |